Fluocinolone Acetonide
Pricing Report NDC 52565-013-15

Latest NADAC: $1.28711 per GM · Effective Jan 18, 2023 · Est. package price $19.31 (15 GM)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Fluocinolone Acetonide (NDC 52565-013-15) is $1.28711 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 18, 2023.

As a provided by Teligent Pharma, Inc., this medication is distributed in a 1 TUBE in 1 CARTON / 15 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.28711
Per GM

Effective Date
Jan 18, 2023
Billable Units
15 GM
Estimated Package Price
$19.31
Data Status
As of Jan 18, 2023
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 TUBE in 1 CARTON / 15 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.71608 to $1.85381 per GM. Over this 9 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.8013 - $1.8538
Market Volatility
131.35% Variance
Latest Trend
12.09%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jan 18, 2023 $1.28711 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 18, 2023 $1.13350 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 21, 2022 $1.46417 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 21, 2022 $0.98850 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2022 $1.51642 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2022 $1.18840 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2022 $1.40294 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2022 $0.95677 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 21, 2022 $0.91458 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 17, 2022 $0.94048 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 20, 2022 $1.28692 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 20, 2022 $1.28692 GMC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026